Fondaparinux is an Anticoagulant Used to Prevent Venous Thromboembolism, Treat Deep Vein Thrombosis and Improve Survival After Myocardial Infarction.
This report aims to provide a comprehensive presentation of the global market for Fondaparinux, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fondaparinux. This report contains market size and forecasts of Fondaparinux in global, including the following market information:
Global Fondaparinux Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Fondaparinux market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Brand Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fondaparinux include Dr. Reddy's Laboratories, Viatris, Abbott, Lee's Pharmaceutical, GlaxoSmithKline, Aspen Pharmacare, Lupin Pharmaceutical, Alchemia and Apicore, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fondaparinux companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fondaparinux Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Fondaparinux Market Segment Percentages, by Type, 2022 (%)
Brand Drug
Generic Drug
Global Fondaparinux Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Fondaparinux Market Segment Percentages, by Application, 2022 (%)
Deep Vein Thrombosis
Acute Coronary Syndrome
Others
Global Fondaparinux Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Fondaparinux Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fondaparinux revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fondaparinux revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy's Laboratories
Viatris
Abbott
Lee's Pharmaceutical
GlaxoSmithKline
Aspen Pharmacare
Lupin Pharmaceutical
Alchemia
Apicore
Jiangsu Hengrui Medicine
Kaifeng Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fondaparinux, market overview.
Chapter 2: Global Fondaparinux market size in revenue.
Chapter 3: Detailed analysis of Fondaparinux company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fondaparinux in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fondaparinux Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fondaparinux Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fondaparinux Overall Market Size
2.1 Global Fondaparinux Market Size: 2022 VS 2030
2.2 Global Fondaparinux Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fondaparinux Players in Global Market
3.2 Top Global Fondaparinux Companies Ranked by Revenue
3.3 Global Fondaparinux Revenue by Companies
3.4 Top 3 and Top 5 Fondaparinux Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fondaparinux Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fondaparinux Players in Global Market
3.6.1 List of Global Tier 1 Fondaparinux Companies
3.6.2 List of Global Tier 2 and Tier 3 Fondaparinux Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fondaparinux Market Size Markets, 2022 & 2030
4.1.2 Brand Drug
4.1.3 Generic Drug
4.2 By Type - Global Fondaparinux Revenue & Forecasts
4.2.1 By Type - Global Fondaparinux Revenue, 2018-2023
4.2.2 By Type - Global Fondaparinux Revenue, 2024-2030
4.2.3 By Type - Global Fondaparinux Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fondaparinux Market Size, 2022 & 2030
5.1.2 Deep Vein Thrombosis
5.1.3 Acute Coronary Syndrome
5.1.4 Others
5.2 By Application - Global Fondaparinux Revenue & Forecasts
5.2.1 By Application - Global Fondaparinux Revenue, 2018-2023
5.2.2 By Application - Global Fondaparinux Revenue, 2024-2030
5.2.3 By Application - Global Fondaparinux Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Fondaparinux Market Size, 2022 & 2030
6.2 By Region - Global Fondaparinux Revenue & Forecasts
6.2.1 By Region - Global Fondaparinux Revenue, 2018-2023
6.2.2 By Region - Global Fondaparinux Revenue, 2024-2030
6.2.3 By Region - Global Fondaparinux Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Fondaparinux Revenue, 2018-2030
6.3.2 US Fondaparinux Market Size, 2018-2030
6.3.3 Canada Fondaparinux Market Size, 2018-2030
6.3.4 Mexico Fondaparinux Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Fondaparinux Revenue, 2018-2030
6.4.2 Germany Fondaparinux Market Size, 2018-2030
6.4.3 France Fondaparinux Market Size, 2018-2030
6.4.4 U.K. Fondaparinux Market Size, 2018-2030
6.4.5 Italy Fondaparinux Market Size, 2018-2030
6.4.6 Russia Fondaparinux Market Size, 2018-2030
6.4.7 Nordic Countries Fondaparinux Market Size, 2018-2030
6.4.8 Benelux Fondaparinux Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Fondaparinux Revenue, 2018-2030
6.5.2 China Fondaparinux Market Size, 2018-2030
6.5.3 Japan Fondaparinux Market Size, 2018-2030
6.5.4 South Korea Fondaparinux Market Size, 2018-2030
6.5.5 Southeast Asia Fondaparinux Market Size, 2018-2030
6.5.6 India Fondaparinux Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Fondaparinux Revenue, 2018-2030
6.6.2 Brazil Fondaparinux Market Size, 2018-2030
6.6.3 Argentina Fondaparinux Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fondaparinux Revenue, 2018-2030
6.7.2 Turkey Fondaparinux Market Size, 2018-2030
6.7.3 Israel Fondaparinux Market Size, 2018-2030
6.7.4 Saudi Arabia Fondaparinux Market Size, 2018-2030
6.7.5 UAE Fondaparinux Market Size, 2018-2030
7 Fondaparinux Companies Profiles
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Company Summary
7.1.2 Dr. Reddy's Laboratories Business Overview
7.1.3 Dr. Reddy's Laboratories Fondaparinux Major Product Offerings
7.1.4 Dr. Reddy's Laboratories Fondaparinux Revenue in Global Market (2018-2023)
7.1.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.2 Viatris
7.2.1 Viatris Company Summary
7.2.2 Viatris Business Overview
7.2.3 Viatris Fondaparinux Major Product Offerings
7.2.4 Viatris Fondaparinux Revenue in Global Market (2018-2023)
7.2.5 Viatris Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Fondaparinux Major Product Offerings
7.3.4 Abbott Fondaparinux Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 Lee's Pharmaceutical
7.4.1 Lee's Pharmaceutical Company Summary
7.4.2 Lee's Pharmaceutical Business Overview
7.4.3 Lee's Pharmaceutical Fondaparinux Major Product Offerings
7.4.4 Lee's Pharmaceutical Fondaparinux Revenue in Global Market (2018-2023)
7.4.5 Lee's Pharmaceutical Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Fondaparinux Major Product Offerings
7.5.4 GlaxoSmithKline Fondaparinux Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Aspen Pharmacare
7.6.1 Aspen Pharmacare Company Summary
7.6.2 Aspen Pharmacare Business Overview
7.6.3 Aspen Pharmacare Fondaparinux Major Product Offerings
7.6.4 Aspen Pharmacare Fondaparinux Revenue in Global Market (2018-2023)
7.6.5 Aspen Pharmacare Key News & Latest Developments
7.7 Lupin Pharmaceutical
7.7.1 Lupin Pharmaceutical Company Summary
7.7.2 Lupin Pharmaceutical Business Overview
7.7.3 Lupin Pharmaceutical Fondaparinux Major Product Offerings
7.7.4 Lupin Pharmaceutical Fondaparinux Revenue in Global Market (2018-2023)
7.7.5 Lupin Pharmaceutical Key News & Latest Developments
7.8 Alchemia
7.8.1 Alchemia Company Summary
7.8.2 Alchemia Business Overview
7.8.3 Alchemia Fondaparinux Major Product Offerings
7.8.4 Alchemia Fondaparinux Revenue in Global Market (2018-2023)
7.8.5 Alchemia Key News & Latest Developments
7.9 Apicore
7.9.1 Apicore Company Summary
7.9.2 Apicore Business Overview
7.9.3 Apicore Fondaparinux Major Product Offerings
7.9.4 Apicore Fondaparinux Revenue in Global Market (2018-2023)
7.9.5 Apicore Key News & Latest Developments
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Company Summary
7.10.2 Jiangsu Hengrui Medicine Business Overview
7.10.3 Jiangsu Hengrui Medicine Fondaparinux Major Product Offerings
7.10.4 Jiangsu Hengrui Medicine Fondaparinux Revenue in Global Market (2018-2023)
7.10.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.11 Kaifeng Pharmaceutical Group
7.11.1 Kaifeng Pharmaceutical Group Company Summary
7.11.2 Kaifeng Pharmaceutical Group Business Overview
7.11.3 Kaifeng Pharmaceutical Group Fondaparinux Major Product Offerings
7.11.4 Kaifeng Pharmaceutical Group Fondaparinux Revenue in Global Market (2018-2023)
7.11.5 Kaifeng Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Fondaparinux Market Opportunities & Trends in Global Market
Table 2. Fondaparinux Market Drivers in Global Market
Table 3. Fondaparinux Market Restraints in Global Market
Table 4. Key Players of Fondaparinux in Global Market
Table 5. Top Fondaparinux Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Fondaparinux Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Fondaparinux Revenue Share by Companies, 2018-2023
Table 8. Global Companies Fondaparinux Product Type
Table 9. List of Global Tier 1 Fondaparinux Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fondaparinux Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Fondaparinux Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Fondaparinux Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Fondaparinux Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Fondaparinux Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Fondaparinux Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Fondaparinux Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Fondaparinux Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Fondaparinux Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Fondaparinux Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Fondaparinux Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Fondaparinux Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Fondaparinux Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Fondaparinux Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Fondaparinux Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Fondaparinux Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Fondaparinux Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Fondaparinux Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Fondaparinux Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Fondaparinux Revenue, (US$, Mn), 2024-2030
Table 30. Dr. Reddy's Laboratories Company Summary
Table 31. Dr. Reddy's Laboratories Fondaparinux Product Offerings
Table 32. Dr. Reddy's Laboratories Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 33. Dr. Reddy's Laboratories Key News & Latest Developments
Table 34. Viatris Company Summary
Table 35. Viatris Fondaparinux Product Offerings
Table 36. Viatris Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 37. Viatris Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Fondaparinux Product Offerings
Table 40. Abbott Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Key News & Latest Developments
Table 42. Lee's Pharmaceutical Company Summary
Table 43. Lee's Pharmaceutical Fondaparinux Product Offerings
Table 44. Lee's Pharmaceutical Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 45. Lee's Pharmaceutical Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Fondaparinux Product Offerings
Table 48. GlaxoSmithKline Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Aspen Pharmacare Company Summary
Table 51. Aspen Pharmacare Fondaparinux Product Offerings
Table 52. Aspen Pharmacare Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 53. Aspen Pharmacare Key News & Latest Developments
Table 54. Lupin Pharmaceutical Company Summary
Table 55. Lupin Pharmaceutical Fondaparinux Product Offerings
Table 56. Lupin Pharmaceutical Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 57. Lupin Pharmaceutical Key News & Latest Developments
Table 58. Alchemia Company Summary
Table 59. Alchemia Fondaparinux Product Offerings
Table 60. Alchemia Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 61. Alchemia Key News & Latest Developments
Table 62. Apicore Company Summary
Table 63. Apicore Fondaparinux Product Offerings
Table 64. Apicore Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 65. Apicore Key News & Latest Developments
Table 66. Jiangsu Hengrui Medicine Company Summary
Table 67. Jiangsu Hengrui Medicine Fondaparinux Product Offerings
Table 68. Jiangsu Hengrui Medicine Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 69. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 70. Kaifeng Pharmaceutical Group Company Summary
Table 71. Kaifeng Pharmaceutical Group Fondaparinux Product Offerings
Table 72. Kaifeng Pharmaceutical Group Fondaparinux Revenue (US$, Mn) & (2018-2023)
Table 73. Kaifeng Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. Fondaparinux Segment by Type in 2022
Figure 2. Fondaparinux Segment by Application in 2022
Figure 3. Global Fondaparinux Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fondaparinux Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Fondaparinux Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fondaparinux Revenue in 2022
Figure 8. By Type - Global Fondaparinux Revenue Market Share, 2018-2030
Figure 9. By Application - Global Fondaparinux Revenue Market Share, 2018-2030
Figure 10. By Type - Global Fondaparinux Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Fondaparinux Revenue Market Share, 2018-2030
Figure 12. By Application - Global Fondaparinux Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Fondaparinux Revenue Market Share, 2018-2030
Figure 14. By Region - Global Fondaparinux Revenue Market Share, 2018-2030
Figure 15. By Country - North America Fondaparinux Revenue Market Share, 2018-2030
Figure 16. US Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Fondaparinux Revenue Market Share, 2018-2030
Figure 20. Germany Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 21. France Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Fondaparinux Revenue Market Share, 2018-2030
Figure 28. China Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 32. India Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Fondaparinux Revenue Market Share, 2018-2030
Figure 34. Brazil Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Fondaparinux Revenue Market Share, 2018-2030
Figure 37. Turkey Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Fondaparinux Revenue, (US$, Mn), 2018-2030
Figure 41. Dr. Reddy's Laboratories Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Viatris Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Lee's Pharmaceutical Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Aspen Pharmacare Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Lupin Pharmaceutical Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Alchemia Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Apicore Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Jiangsu Hengrui Medicine Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Kaifeng Pharmaceutical Group Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
